ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,308.15
1.17%
US Tech 100
18,146.80
0.17%
Dow Jones
39,908.00
0.00%
Brent Oil
82.505
-0.18%
Bitcoin
66,150.85
-0.16%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/16/20247:37AMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:MAPTMAPtelligent Inc (PK)
05/16/20247:36AMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CETUWCetus Capital Acquisition Corporation
05/16/20247:35AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:WKSPWWorksport Ltd
05/16/20247:35AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:GTLLGlobal Technologies Ltd (PK)
05/16/20247:35AMBusiness WireDC BLOX Completes Myrtle Beach to Atlanta Dark Fiber Route
05/16/20247:34AMAlliance NewsAlliance NewsIN BRIEF: H&T sees "record" month after strong start to yearLSE:HATH&t Group Plc
05/16/20247:34AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:JFBRWJeffs Brands Ltd
05/16/20247:33AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:ZTOZTO Express Cayman Inc
05/16/20247:33AMPR Newswire (US)Realizeit To Showcase Business-Critical Training Powered by AI at ATD24 Conference and EXPO
05/16/20247:32AMPR Newswire (Canada)Élever un enfant au Québec coûte près de 400 000$
05/16/20247:31AMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:WKSPWWorksport Ltd
05/16/20247:31AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MRXMarex Group PLC
05/16/20247:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XOMAPXOMA Corporation
05/16/20247:31AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:WFWoori Financial Group Inc
05/16/20247:31AMPR Newswire (US)Metabolon Secures $60 Million Credit Facility to Drive Growth and InnovationNASDAQ:TRINTrinity Capital Inc
05/16/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:GEOGeo Group Inc New
05/16/20247:30AMGlobeNewswire Inc.BW Offshore: Invitation to Q1 2024 Presentation 24 May
05/16/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NMHIWNatures Miracle Holding Inc
05/16/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGFYAgrify Corporation
05/16/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:MLMoneyLion Inc
05/16/20247:30AMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:CGEMCullinan Therapeutics Inc
05/16/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NNNNNN REIT Inc
05/16/20247:30AMGlobeNewswire Inc.FTI Consulting Expands Healthcare Business Transformation Practice with Appointment of Digital Strategy ExpertNYSE:FCNFTI Consulting Inc
05/16/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:TOVXTheriva Biologics Inc
05/16/20247:30AMGlobeNewswire Inc.Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral SclerosisNASDAQ:BIIBBiogen Inc
05/16/20247:30AMGlobeNewswire Inc.Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral SclerosisLSE:0R1BBiogen Inc
05/16/20247:30AMGlobeNewswire Inc.Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral SclerosisBIT:1BIIBBiogen Inc
05/16/20247:30AMGlobeNewswire Inc.Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral SclerosisTG:IDPBiogen Inc
05/16/20247:30AMGlobeNewswire Inc.Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral SclerosisXE:IDPBiogen Inc
05/16/20247:30AMGlobeNewswire Inc.Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral SclerosisNASDAQ:IONSIonis Pharmaceuticals Inc

Your Recent History

USOTC
RXMD
Progressive Care (QB)
USOTC
IQST
iQSTEL (QX)
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
GDVM
Global Developments (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
EPAZ
Epazz (PK)
USOTC
HNRC
Houston Natural Resources (PK)
AMEX
SPY
SPDR S&P 500
USOTC
CGAC
Code Green Apparel (PK)
USOTC
SPZI
Spooz (PK)
USOTC
IBGR
Nexus Energy Services (PK)
USOTC
FBEC
FBEC Worldwide (CE)
USOTC
NSAV
Net Savings Link (PK)
USOTC
MVNT
Movement Industries (PK)
USOTC
HMBL
HUMBL (PK)
USOTC
SAPX
Seven Arts Entertainment (PK)
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved